ArticleThe New England journal of medicine2021
Lenvatinib plus Pembrolizumab for Renal Cell Carcinoma. Reply.
Robert Motzer et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
10 papers cite it
this paperpooled itcites it
ArticleThe New England journal of medicine2021
Robert Motzer et al.PubMed ↗Publisher ↗
No numbers read from the abstract.